Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM — Stella

Home/Achalasia/

View on ClinicalTrials.gov

Recruiting

Back to Achalasia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Ecuador

academy tertiary, IECED, Guayaquil

Hong Kong

Department of Surgery, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong

Key details

Sponsor

Chinese University of Hong Kong

Collaborators

Academy tertiary center, IECED, Guayaquil, Ecuador

Enrollment target

~73 participants

Started

November 2024

Primary completion

October 2026

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.